Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
The Journal of Cell Biology|May 17, 2019
The PHLPP2 phosphatase is a druggable driver of prostate cancer progressionDawid G Nowak, Ksenya Cohen Katsenelson, Kaitlin E Watrud, et al.Cancer Cell|August 16, 2011
Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progressionMuhan Chen, Christopher P Pratt, Martha E Zeeman, et al.Cancer Research|November 29, 2017
Utility of Single-Cell Genomics in Diagnostic Evaluation of Prostate CancerJoan Alexander, Jude Kendall, Jean McIndoo, et al.The Journal of Experimental Medicine|July 8, 2020
SOAT1 promotes mevalonate pathway dependency in pancreatic cancerTobiloba E Oni, Giulia Biffi, Lindsey A Baker, et al.Science (New York, N.Y.)|September 29, 2018
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in miceJean Albrengues, Mario A Shields, David Ng, et al.The Journal of Cell Biology|February 15, 2017
The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN proteinMuhan Chen, Dawid G Nowak, Navneet Narula, et al.Cancer Cell|March 1, 2024
Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cellsManuel Colucci, Sara Zumerle, Silvia Bressan, et al.Cancer Discovery|April 4, 2024
Next Directions in the Neuroscience of Cancers Arising outside the CNSMoran Amit, Corina Anastasaki, Robert Dantzer, et al.Cell|April 18, 2020
Roadmap for the Emerging Field of Cancer NeuroscienceMichelle Monje, Jeremy C Borniger, Nisha J D'Silva, et al.Science Signaling|July 3, 2014
A unified nomenclature and amino acid numbering for human PTENRafael Pulido, Suzanne J Baker, Joao T Barata, et al.Pageof 6